Composition for targeted cell treatment
OwnerVincent Marinkovichinventor
Life of this patent
Estimating the term…
Abstract
Compositions, vaccines and kits for cancer immunotherapy are described. The compositions, vaccines and kits may include transfer factor. The compositions, vaccines and kits also include modified monoclonal antibodies directed to cancer cells, other specific cancer receptor agonists, or viruses which infect cancer cells. The invention is also directed to methods of cancer immunotherapy using the compositions and vaccines of the invention.
Claims9
A composition comprising a monoclonal antibody directed to a cancer cell and transfer factor wherein the monoclanal antibody is conjugated to a fungal antigen or mumps virus.
The composition according to clam 1 wherein the monoclonal antibody is selected from the group consisting of 17-1A, CC49, EGFr surface factor, anti MC-10 antigen, anti-HER2, anti-CD20, NR-LU-10 and MDX-H210.
A kit comprising a monoclonal antibody directed to a cancer cell and a transfer factor wherein the monoclonal antibody is conjugated to a fungal antigen or mumps virus.
Dependencies are inferred from the claim text.